Kimia Biosciences Limited (BOM:530313)
India · Delayed Price · Currency is INR 31.61
+0.61 (1.97%)
At close: Jul 31, 2026
Kimia Biosciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,496 | 1,114 | 2,011 | 2,637 | 1,538 | 1,779 | |
Market Cap Growth | -48.64% | -44.60% | -23.72% | 71.48% | -13.56% | -0.92% |
Enterprise Value | 1,835 | 1,468 | 2,406 | 3,205 | 2,079 | 2,253 |
Last Close Price | 31.61 | 23.55 | 42.51 | 55.73 | 32.50 | 37.60 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 19.27 | 14.99 | 20.92 | - | - | - |
PS Ratio | 1.30 | 0.97 | 1.69 | 2.51 | 1.20 | 1.42 |
PB Ratio | 8.44 | 6.29 | 20.18 | 796.60 | 28.15 | 11.95 |
P/TBV Ratio | 14.08 | 10.49 | 20.23 | 908.91 | 28.59 | 12.07 |
P/FCF Ratio | 55.75 | 41.53 | 12.03 | 20.24 | - | 40.28 |
P/OCF Ratio | 13.79 | 10.28 | 9.44 | 18.14 | - | 22.25 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.60 | 1.28 | 2.02 | 3.06 | 1.62 | 1.80 |
EV/EBITDA Ratio | 12.86 | 10.29 | 11.98 | 1176.42 | - | 372.40 |
EV/EBIT Ratio | 17.72 | 14.18 | 14.26 | - | - | - |
EV/FCF Ratio | 68.41 | 54.72 | 14.40 | 24.60 | - | 51.01 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 1.96 | 1.96 | 3.95 | 149.59 | 10.66 | 3.06 |
Debt / EBITDA Ratio | 2.44 | 2.44 | 1.95 | 176.14 | - | 75.21 |
Debt / FCF Ratio | 12.97 | 12.97 | 2.36 | 3.80 | - | 10.30 |
Net Debt / Equity Ratio | 1.92 | 1.92 | 3.93 | 149.14 | 10.62 | 3.04 |
Net Debt / EBITDA Ratio | 2.38 | 2.38 | 1.95 | 181.23 | -19.32 | 74.77 |
Net Debt / FCF Ratio | 12.66 | 12.66 | 2.34 | 3.79 | -6.05 | 10.24 |
Asset Turnover | 1.07 | 1.07 | 1.13 | 0.95 | 1.11 | 1.16 |
Inventory Turnover | 2.31 | 2.31 | 2.21 | 1.94 | 2.29 | 3.08 |
Quick Ratio | 0.49 | 0.49 | 0.46 | 0.41 | 0.41 | 0.55 |
Current Ratio | 1.04 | 1.04 | 0.92 | 0.88 | 1.08 | 1.18 |
Return on Equity (ROE) | 53.70% | 53.70% | 186.70% | -183.25% | -91.91% | -22.22% |
Return on Assets (ROA) | 6.04% | 6.04% | 9.99% | -1.67% | -3.40% | -1.32% |
Return on Invested Capital (ROIC) | 18.45% | 18.05% | 24.07% | -5.24% | -10.15% | -3.60% |
Return on Capital Employed (ROCE) | 24.60% | 24.60% | 57.40% | -9.70% | -14.00% | -4.80% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 4.97% | 6.67% | 4.78% | -2.01% | -6.08% | -2.08% |
FCF Yield | 1.79% | 2.41% | 8.31% | 4.94% | -6.23% | 2.48% |
Buyback Yield / Dilution | 4.20% | 4.20% | - | - | - | - |